CEL-SCI Corporation
Quick facts
Marketed products
- LI · Oncology
LI is an immunotherapeutic agent designed to enhance immune response against cancer cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: